semaglutide and kidney problems FLOW clinical Trial (funded by Novo Nordisk): showed 24% reduction in the risk of disease-related events in people with type 2 diabetes chronic kidney disease compared to placebo. Investigators Long-term kidney outcomes of semaglutide

What Should You Tell Patients About GLP-1 Use in Pregnancy

By Lisa Gonzalez, APRN-BC In recent years, the quest for effective weight loss solutions and cholesterol management has gained significant attention due

Semaglutide reduces hunger by slowing stomach emptying and activating brain satiety centers

Clean, Vegan & Allergen-Free Formula: MuseBeam 12-in-1 GLP-1 Support Weight Loss Probiotic is crafted with care to be free from gluten, sugar, dairy, soy, preservatives, and artificial additives

Their programs include GLP1 and tirzepatide therapies, prescription medication tracks, supplementation (B12, lipotropics), and nutrition & lifestyle coaching

Since GLP-1 may play a role in the pathophysiology and treatment of type 2 diabetes, assessment of meal-related GLP-1 secretory responses in type 2 diabetic patients vs healthy individuals is of great interest